Building Global Antibiotic Resistance Monitoring Capacities

Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.

Segment Description: Dr. Pol Vandenbroucke, Chief Medical Officer for Pfizer’s hospital business unit, describes efforts to build up capacity for antimicrobial resistance surveillance in low- and middle-income countries. Dr. Vandenbroucke also explains how the development of both health and civil society infrastructure around the world helps to slow antimicrobial resistance.

Related Content:

ANTIBIOTICSPREVENTIONVideos
The Role of a Stewardship Pharmacist in Treating UTIs in the Outpatient Setting
Hospital Discharge a Key Opportunity to Practice Antimicrobial Stewardship
Vancomycin With a β-Lactam: Comparing Acute Kidney Injury Rates of Trough vs AUC Dosing